References

Cure Arthritis Naturally

Cure Arthritis Naturally

Get Instant Access

1. Kaandorp CJE, Dinant HJ, van de Laar MAFJ et al. Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis 1997;56:470-5.

2. Dubost JJ, Soubrier M, Sauvezie B. Pyogenic arthritis in adults. Joint Bone Spine 2000;67:11-21.

3. Gillespie WJ. The epidemiology of acute haematogenous osteomyelitis of childhood. Int J Epidemiol 1985;14:600-6.

4. Weston VC, Jones AC, Bradbury N, Fawthrop F, Doherty M. Clinical features and outcome of septic arthritis in a single UK Health District 1982-1991. Ann Rheum Dis 1999;58:214-19.

5. Morgan DS, Fisher D, Merianos A, Currie BJ. An 18 year clinical review of septic arthritis from tropical Australia. Epidemiol Infect 1996;117:423-8.

6. David-Chaussé J, Dehais J, Boyer M, Darde ML. Les infections articulaires chez l'adulte; atteintes périphériques et vertébrales à germes banal et à bacilles tuberculeux. Rev Rhum Mal Ostéoartic 1981;48:69-76.

7. Ryan MJ, Kavanagh R, Wall PG, Hazleman BL. Bacterial joint infections in England and Wales: analysis of bacterial isolates over a 4 year period. Br J Rheumatol 1997;36:370-3.

8. Murrell GAC, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995;206:15-21.

9. Lee MS, Yen CY, Ueng SW, Shih CH, Chao CC. Signal transduction pathways and apoptosis in bacteria infected chondrocytes. J Orthop Res 2001;19:696-702.

10. Gupta MN, Sturrock RD, Field M. A prospective 2-year study of 75 patients with adult-onset septic arthritis. Rheumatology 2001;40:24-30.

11. Norden C, Nelson JD, Mader JT, Calandra GB. Evaluation of new anti-infective drugs for the treatment of infectious arthritis in adults. Clin Infect Dis 1992;15(Suppl. 1):S167-S171.

12. Jalava J, Skurnik M, Toivanen A, Toivanen P, Eerola E. Bacterial PCR in the diagnosis of joint infection. Ann Rheum Dis 2001;60:287-9.

13. Von Essen R. Culture of joint specimens in bacterial arthritis. Impact of blood culture bottle utilization. Scand J Rheumatol 1997;26:293-300.

14. Yagupsky P, Press J. Use of the isolator 1.5 microbial tube for culture of synovial fluid from patients with septic arthritis. J Clin Microbiol 1997;35:2410-12.

15. Kortekangas P, Peltola O, Toivanen A, Aro HT. Synovial fluid L-lactic acid in acute arthritis of the adult knee joint. Scand J Rheumatol 1995;24:98-101.

16. Shmerling RH, Delbanco TL, Tosteson AN, Trentham DE. Synovial fluid tests. What should be ordered? JAMA 1990;264:1009-14.

17. Piriou P, Garreau DL, Wattincourt L, Judet T. Simple punction versus notch needle-biopsy for bacteriological diagnosis of osteoarticular infection. A prospective study on 54 cases. [French] Rev Chir Orthop Reparatrice Appar Mot 1998;84:685-8.

18. Stutz G, Kuster MS, Kleinstuck F, Gachter A. Arthroscopic management of septic arthritis: stages of infection and results. Knee Surg Sports Traumatol Arthrosc 2000;8: 270-4.

19. Nord KD, Dore DD, Deeney VF et al. Evaluation of treatment modalities for septic arthritis with histological grading and analysis of levels of uronic acid, neutral protease, and interleukin-1. J Bone Joint Surg Am 1995;77:258-65.

20. Lidgren L. Joint prosthetic infections: A success story Acta Orthop Scand 2001;72:553-6.

21. Berbari EF, Hanssen AD, Duffy MC et al. Risk factors for prosthetic joint infection: Case-control study. Clin Infect Dis 1998;27:1247-54.

22. Peersman G, Laskin R, Davis J, Peterson M. The Insall award paper: Infection in total knee replacement: A retrospective review of 6489 total knee replacements. Clin Orthop 2001;392:15-23.

23. Haley RW. Nosocomial infections in surgical patients: developing valid measures of intrinsic patient risk. Am J Med 1991;91(3B):145S-151S.

24. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284:1318-22.

25. van de Belt H, Neut D, Schenk W et al. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand 2001;72: 557-71.

26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Ass 1958;53:457-81.

27. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.

28. Coventry MB. Treatment of infections occurring in total hip surgery. Orthop Clin N Amer 1975;6:991-1003.

29. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998;279:1537-41.

30. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996;78:512-23.

31. Callaghan JJ, Katz RP, Johnston RC. One-stage revision surgery of the infected hip. A minimum 10-year followup study. Clin Orthop 1999;369:139-43.

32. Raut VV, Siney PD, Wroblewski BM. One-stage revision of total hip arthroplasty for deep infection. Long-term followup. Clin Orthop 1995;321:202-7.

33. Brandt CM, Sistrunk WW, Duffy MC et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997;24:914-19.

34. Blaser J, Vergeres P, Widmer AF, Zimmerli W. In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob Agents Chemother 1995;39:1134-9.

35. Fisman DN, Reilly DT, Karchmer AW, Goldie SJ. Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis 2001;32:419-30.

36. Josefsson G, Gudmundsson G, Kolmert L, Wijkstrom S. Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty. A 5-year survey of 1688 hips. Clin Orthop 1990;253:173-8.

37. Espehaug B, Engesaeter LB, Vollset SE, Havelin LI, Langeland N. Antibiotic prophylaxis in total hip arthroplasty. J Bone Joint Surg Br 1997;79:590-5.

38. Moller AM, Villebro N, Pedersen T, Tonnesen H. Effect of preoperative smoking intervention on postoperative complications: A randomized clinical trial. Lancet 2002;359:114-17.

39. Bridges Jr SL, Lopez-Mendez A, Han KH, Tracy IC, Alarcon GS. Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis? J Rheumatol 1991;18:984-8.

40. Carpenter MT, West SG, Vogelgesang SA, Casey Jones DE. Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy. Orthopedics 1996;19:207-10.

41. Boulton AJ. The diabetic foot: a global view. Diab Metab Res Rev2000;16(Suppl. 1): S2-S5.

42. Muller IS, de Grauw WJ, van Gerwen WH etal. Foot ulceration and lower limb amputation in type 2 diabetic patients in Dutch primary health care. Diab Care 2002;25:570-4.

43. Eneroth M, Larsson J, Apelqvist J. Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis. J Diab Complic 1999;13:254-63.

44. Tomas MB, Patel M, Marwin SE, Palestro CJ. The diabetic foot. Br J Radiol 2000;73:443-50.

45. Boyko EJ, Ahroni JH, Stensel V etal. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diab Care 1999;22:1036-42.

46. Peters EJ, Lavery LA. Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diab Care 2001;24:1442-7.

47. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995;273:721-3.

48. Bonham P. A critical review of the literature: part I: diagnosing osteomyelitis in patients with diabetes and foot ulcers. J Wound Ostomy Continence Nurs 2001;28:73-88.

49. Howard CB, Einhorn M, Dagan R, Yagupski P, Porat S. Fine-needle bone biopsy to diagnose osteomyelitis. J Bone Joint Surg Br 1994;76:311-14.

50. Snyder RJ, Cohen MM, Sun C, Livingston J. Osteomyelitis in the diabetic patient: diagnosis and treatment. Part 1: Overview, diagnosis, and microbiology. Ostomy Wound Manage 2001;47:18-30.

51. Pittet D, Wyssa B, Herter-Clavel C et al. Outcome of diabetic foot infections treated conservatively: A retrospective cohort study with long-term follow up. Arch Intern Med 1999;159:851-6.

52. Lipsky BA. Evidence-based antibiotic therapy of diabetic foot infections. FEMS Immunol Med Microbiol 1999;26:267-76.

53. Stengel D, Bauwens K, Sehouli J, Ekkernkamp A, Porzsolt F. Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect Dis 2001;1:175-88.

54. Norden CW, Bryant R, Palmer D, Montgomerie JZ, Wheat J. Chronic osteomyelitis caused by Staphylococcus aureus: controlled clinical trial of nafcillin therapy and nafcillin-rifampin therapy. South Med J 1986;79:947-51.

55. Senneville E, Yazdanpanah Y, Cazaubiel M et al. Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. J Antimicrob Chemother 2001;48:927-30.

56. de Lalla F, Pellizzer G, Strazzabosco M et al. Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chemother 2001;45:1094-8.

57. Pinzur MS, Smith D, Osterman H. Syme ankle disarticulation in peripheral vascular disease and diabetic foot infection: the one-stage versus two-stage procedure. Foot Ankle Int 1995;16:124-7.

58. Mason J, O'Keeffe C, McIntosh A et al. A systematic review of foot ulcer in patients with Type 2 diabetes mellitus. I: prevention. Diabet Med 1999;16:801-12.

59. Mason J, O'Keeffe C, Hutchinson A et al. A systematic review of foot ulcer in patients with Type 2 diabetes mellitus. II: treatment. Diabet Med 1999;16:889-909.

60. Chantelau E, Tanudjaja T, Altenhofer F et al. Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: A controlled trial. Diabet Med 1996;13:156-9.

61. Leslie CA, Sapico FL, Ginunas VJ, Adkins RH. Randomized controlled trial of topical hyperbaric oxygen for treatment of diabetic foot ulcers. Diab Care 1988;11:111-15.

62. Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: A prospective randomized multicenter clinical trial. Diab Care 2001;24:290-5.

Was this article helpful?

0 0
Arthritis Relief and Prevention

Arthritis Relief and Prevention

This report may be oh so welcome especially if theres no doctor in the house Take Charge of Your Arthritis Now in less than 5-Minutes the time it takes to make an appointment with your healthcare provider Could you use some help understanding arthritis Maybe a little gentle, bedside manner in your battle for joint pain relief would be great Well, even if you are not sure if arthritis is the issue with you or your friend or loved one.

Get My Free Ebook


Post a comment